| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL ARTICLES |
From the 1Renal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston; 2Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts; 3Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts; and 4Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
OBJECTIVE: Women with a history of gestational diabetes mellitus (GDM) are at high risk for developing type 2 diabetes (diabetes mellitus, DM). The American Diabetes Association recommends regular postpartum diabetes screening for women with a history of GDM, but the American College of Obstetricians and Gynecologists (ACOG) is not as directive. We sought to examine postpartum glycemic testing in women diagnosed with GDM.
METHODS: We conducted an observational cohort study of women diagnosed with GDM at one of two large academic medical centers between 2000 and 2001. Kaplan-Meier estimates of the time from delivery to the first postpartum DM screening tests were determined, and predictors of postpartum DM screening were examined using Cox proportional hazards testing.
RESULTS: Only 37% of eligible women underwent the postpartum diabetes screening tests recommended by the American Diabetes Association (fasting glucose or oral glucose tolerance test [OGTT]), with a median time from delivery to the first such testing of 428 days. By comparison, 94% of women underwent postpartum cervical cancer screening using a Papanicolaou (Pap) test, with a median time from delivery to Pap testing of 49 days. Even when random glucose testing was included in a broad definition of postpartum DM screening (random or fasting glucose, glycosylated hemoglobin, or OGTT), only two thirds of women (67%) received a postpartum glycemic assessment.
CONCLUSION: In the population studied, only 37% of women with a history of GDM were screened for postpartum DM according to guidelines published by the American Diabetes Association. Efforts to improve postpartum DM screening in this high-risk group are warranted.
LEVEL OF EVIDENCE: II-2
This article has been cited by other articles:
|
|
 |
|
  P. M. Dietz, K. K. Vesco, W. M. Callaghan, D. J. Bachman, F. C. Bruce, C. J. Berg, L. J. England, and M. C. Hornbrook Postpartum Screening for Diabetes After a Gestational Diabetes Mellitus-Affected Pregnancy Obstet. Gynecol., October 1, 2008; 112(4): 868 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Holman A Call to Step Up Postgestational Diabetes Screening DOC News, October 1, 2007; 4(10): 1 - 12. [Full Text]
|
|
|
|
 |
|
 C. Kim, L. N. McEwen, E. A. Kerr, J. D. Piette, M. C. Chames, A. Ferrara, and W. H. Herman Preventive Counseling Among Women With Histories of Gestational Diabetes Mellitus Diabetes Care, October 1, 2007; 30(10): 2489 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Y. Chu, W. M. Callaghan, S. Y. Kim, C. H. Schmid, J. Lau, L. J. England, and P. M. Dietz Maternal Obesity and Risk of Gestational Diabetes Mellitus Diabetes Care, August 1, 2007; 30(8): 2070 - 2076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Kitzmiller, L. Dang-Kilduff, and M. M. Taslimi Gestational Diabetes After Delivery: Short-term management and long-term risks Diabetes Care, July 1, 2007; 30(Supplement_2): S225 - S235. [Full Text] [PDF]
|
|
|
|
|
|
R. E. Ratner Prevention of Type 2 Diabetes in Women With Previous Gestational Diabetes Diabetes Care, July 1, 2007; 30(Supplement_2): S242 - S245. [Full Text] [PDF]
|
|
|
|
|
|
C. Kim, W. H. Herman, and S. Vijan Efficacy and Cost of Postpartum Screening Strategies for Diabetes Among Women With Histories of Gestational Diabetes Mellitus Diabetes Care, May 1, 2007; 30(5): 1102 - 1106. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
